A novel selective inhibitor for plasma membrane calcium ATPase 4 improves VEFG-mediated angiogenesis
Ischaemic cardiovascular diseases are the leading cause of death worldwide. Therapeutic angiogenesis provides a valuable tool to treat these conditions by stimulating the growth of new blood vessels in the ischaemic tissue. The pro-angiogenic factor VEGF is the most potent inducer of angiogenesis, a...
Main Author: | |
---|---|
Published: |
University of Wolverhampton
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.725318 |